Protagonist Therapeutics
PTGX
PTGX
144 hedge funds and large institutions have $946M invested in Protagonist Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 40 reducing their positions, and 39 closing their positions.
Holders
144
Holders Change
-22
Holders Change %
-13.25%
% of All Funds
2.3%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
17
Increased
65
Reduced
40
Closed
39
Calls
$12.2M
Puts
$1.14M
Net Calls
+$11.1M
Net Calls Change
-$15.7M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BCM
176
Bayesian Capital Management
Brooklyn,
New York
| – | -$254K | -9,211 | Closed |
|
177
Verition Fund Management
Greenwich,
Connecticut
| – | -$254K | -9,210 | Closed |
|
|
AIM
178
Aigen Investment Management
New York
| – | -$208K | -7,527 | Closed |
|
|
NA
179
NewEdge Advisors
New Orleans,
Louisiana
| – | -$89.2K | -3,230 | Closed |
|
|
S
180
SignatureFD
Atlanta,
Georgia
| – | -$911 | -33 | Closed |
|
|
FGAM
181
Financial Gravity Asset Management
Lakeway,
Texas
| – | -$470 | -28 | Closed |
|